Longitudinal Subtyping Of Atopic Dermatitis Through Skin AnalysisResearch Question:
Is the type 2-high non-lesional skin (skin tape) type is associated with mild versus
moderate-to-severe atopic dermatitis?
Basic Study Information
Purpose:Location: University of Rochester Medical Center: Department of Dermatology
This is a study which will characterize the gene expression
profiles that underlie mild and moderate-severe Atopic
dermatitis (AD). It will determine changes in these expression patterns in
response to standard-of-care treatment. Participants will complete up to ten study
with assessment of topical steroid response and dupilumab response (if uncontrolled
topical steroids). Skin samples will be collected at all study visits to determine
expression profiles that underlie mild vs. moderate-severe atopic dermatitis.
Healthy participants without atopic dermatitis will serve as a control population
and must agree to apply a topical moisturizer (Vanicream) at least twice daily for
Atopic dermatitis patients must have chronic AD with active lesions.
Study Reference #: 22-10-184-754
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Michelle Smith
Phone: (585) 275-0374
Additional Study Details
Currently not recruiting healthy participants.
Number of Visits:
6 to 10
Study reimbursement also includes a $20 travel stipend per visit.
Learn More About These Conditions
More information about Dermatitis
More information about Dermatitis, Atopic
More information about Eczema
Trial Not Found
The study you are looking for is not active at this time.
Return to Search